newsfilter
← Latest News
GlobeNewswire·

Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study

Company to leverage strong durability and survival data in second-line and later metastatic squamous cell anal carcinoma Pivotal study expected to focus on patients in a post-standard-of-care patient population with no